Predictive oncology reports third quarter financial results

Eagan, minn., nov. 10, 2021 (globe newswire) -- results from the third quarter show strong potential for future growth, said predictive oncology (nasdaq: poai) today, announcing financial results for the quarter ended september 30, 2021. all three of predictive oncology's reportable segments recognized revenue for the quarter, and the loss per common share was reduced to $0.08, compared to $0.46 for the same period in 2020.
POAI Ratings Summary
POAI Quant Ranking